|
1.
|
Bland D, Fankhanel Y, Langford E, et al:
Intensive versus modified conventional control of blood glucose
level in medical intensive care patients: a pilot study. Am J Crit
Care. 14:370–376. 2005.PubMed/NCBI
|
|
2.
|
Finfer S, Chittock D, Su S, et al:
Intensive versus conventional glucose control in critically ill
patients. N Engl J Med. 360:1283–1297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Van den Berghe G, Wouters P, Weekers F, et
al: Intensive insulin therapy in the critically ill patients. N
Engl J Med. 345:1359–1367. 2001.
|
|
4.
|
Van den Berghe G: How does blood glucose
control with insulin save lives in intensive care? J Clin Invest.
114:1187–1195. 2004.PubMed/NCBI
|
|
5.
|
Van den Berghe G, Schetz M, Vlasselaers D,
et al: Clinical review: Intensive insulin therapy in critically ill
patients: NICE-SUGAR or Leuven blood glucose target? J Clin
Endocrinol Metab. 94:3163–3170. 2009.PubMed/NCBI
|
|
6.
|
Foster K, Oster C, Mayer M, Avery M and
Audus K: Characterization of the A549 cell line as a type II
pulmonary epithelial cell model for drug metabolism. Exp Cell Res.
243:359–366. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Nardone LL and Andrews SB: Cell line A549
as a model of the type II pneumocyte. Phospholipid biosynthesis
from native and organometallic precursors. Biochim Biophys Acta.
573:276–295. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ladenburger A, Seehase M, Kramer BW, et
al: Glucocorticoids potentiate IL-6-induced SP-B expression in H441
cells by enhancing the JAK-STAT signaling pathway. Am J Physiol
Lung Cell Mol Physiol. 299:L578–L584. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Chess PR, Ryan RM and Finkelstein JN: H441
pulmonary epithelial cell mitogenic effects and signaling pathways
in response to HGF and TGF-alpha. Exp Lung Res. 24:27–39. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Miakotina OL, Dekowski SA and Snyder JM:
Insulin inhibits surfactant protein A and B gene expression in the
H441 cell line. Biochim Biophys Acta. 1442:60–70. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Miakotina OL, Goss KL and Snyder JM:
Insulin utilizes the PI 3-kinase pathway to inhibit SP-A gene
expression in lung epithelial cells. Respir Res. 3:272002.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Holmskov U, Malhotra R, Sim R and
Jensenius J: Collectins: collagenous C-type lectins of the innate
immune defense system. Immunol Today. 15:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Chaby R, Garcia-Verdugo I, Espinassous Q
and Augusto LA: Interactions between LPS and lung surfactant
proteins. J Endotoxin Res. 11:181–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
McCormack F, Gibbons R, Ward S, Kuzmenko
A, Wu H and Deepe GJ: Macrophage-independent fungicidal action of
the pulmonary collectins. J Biol Chem. 278:36250–36256. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wu H, Kuzmenko A, Wan S, et al: Surfactant
proteins A and D inhibit the growth of Gram-negative bacteria by
increasing membrane permeability. J Clin Invest. 111:1589–1602.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
van Iwaarden F, Welmers B, Verhoef J,
Haagsman H and van Golde L: Pulmonary surfactant protein A enhances
the host-defense mechanism of rat alveolar macrophages. Am J Respir
Cell Mol Biol. 2:91–98. 1990.PubMed/NCBI
|
|
17.
|
Deb R, Shakib F, Reid K and Clark H: Major
house dust mite allergens Dermatophagoides pteronyssinus 1
and Dermatophagoides farinae 1 degrade and inactivate lung
surfactant proteins A and D. J Biol Chem. 282:36808–36819.
2007.PubMed/NCBI
|
|
18.
|
Vandivier RW, Ogden CA, Fadok VA, et al:
Role of surfactant proteins A, D, and C1q in the clearance of
apoptotic cells in vivo and in vitro: calreticulin and CD91 as a
common collectin receptor complex. J Immunol. 169:3978–3986. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Borron P, Veldhuizen RA, Lewis JF, et al:
Surfactant associated protein-A inhibits human lymphocyte
proliferation and IL-2 production. Am J Respir Cell Mol Biol.
15:115–121. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Borron P, McCormack FX, Elhalwagi BM, et
al: Surfactant protein A inhibits T cell proliferation via its
collagen-like tail and a 210-kDa receptor. Am J Physiol.
275:L679–L686. 1998.PubMed/NCBI
|
|
21.
|
Nogee L: Genetic mechanisms of surfactant
deficiency. Biol Neonate. 85:314–318. 2004. View Article : Google Scholar
|
|
22.
|
Serrano AG and Pérez-Gil J: Protein-lipid
interactions and surface activity in the pulmonary surfactant
system. Chem Phys Lipids. 141:105–118. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Cruz A, Worthman LA, Serrano AG, Casals C,
Keough KM and Pérez-Gil J: Microstructure and dynamic surface
properties of surfactant protein
SP-B/dipalmitoylphosphatidylcholine interfacial films spread from
lipid-protein bilayers. Eur Biophys J. 29:204–213. 2000. View Article : Google Scholar
|
|
24.
|
Beers M, Hamvas A, Moxley M, et al:
Pulmonary surfactant metabolism in infants lacking surfactant
protein B. Am J Respir Cell Mol Biol. 22:380–391. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Besnard V, Wert SE, Kaestner KH and
Whitsett JA: Stage-specific regulation of respiratory epithelial
cell differentiation by Foxa1. Am J Physiol Lung Cell Mol Physiol.
289:L750–L759. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Weaver TE and Conkright JJ: Function of
surfactant proteins B and C. Annu Rev Physiol. 63:555–578. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Clark JC, Wert SE, Bachurski CJ, et al:
Targeted disruption of the surfactant protein B gene disrupts
surfactant homeostasis, causing respiratory failure in newborn
mice. Proc Natl Acad Sci USA. 92:7794–7798. 1995. View Article : Google Scholar
|
|
28.
|
Boggaram V: Regulation of lung surfactant
protein gene expression. Front Biosci. 8:d751–d764. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Zhou L, Lim L, Costa RH and Whitsett JA:
Thyroid transcription factor-1, hepatocyte nuclear factor-3beta,
surfactant protein B, C, and Clara cell secretory protein in
developing mouse lung. J Histochem Cytochem. 44:1183–1193. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Stahlman MT, Gray ME and Whitsett JA:
Temporal-spatial distribution of hepatocyte nuclear factor-3beta in
developing human lung and other foregut derivatives. J Histochem
Cytochem. 46:955–962. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Mendelson CR: Endocrinology of the Lung:
Development and Surfactant Synthesis. Humana Press; Totowa, New
Jersey: pp. 2000
|
|
32.
|
Mendelson CR and Boggaram V: Regulation of
pulmonary surfactant protein synthesis in fetal lung: a major role
of glucocorticoids and cyclic AMP. Trends Endocrinol Metab.
1:20–25. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Boggaram V, Chandru H, Gottipati KR,
Thakur V, Das A and Berhane K: Transcriptional regulation of SP-B
gene expression by nitric oxide in H441 lung epithelial cells. Am J
Physiol Lung Cell Mol Physiol. 299:L252–L262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Silveyra P and Floros J: Genetic
complexity of the human surfactant-associated proteins SP-A1 and
SP-A2. Gene. 2012.
|
|
35.
|
Kumar A and Snyder J: Differential
regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and
insulin. Am J Physiol. 274:L177–L185. 1998.PubMed/NCBI
|
|
36.
|
Mouhieddine-Gueddiche OB, Pinteur C,
Chailley-Heu B, Barlier-Mur AM, Clement A and Bourbon JR:
Dexamethasone potentiates keratinocyte growth factor-stimulated
SP-A and SP-B gene expression in alveolar epithelial cells. Pediatr
Res. 53:231–239. 2003. View Article : Google Scholar
|
|
37.
|
Salinas D, Sparkman L, Berhane K and
Boggaram V: Nitric oxide inhibits surfactant protein B gene
expression in lung epithelial cells. Am J Physiol Lung Cell Mol
Physiol. 285:L1153–L1165. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Liu D, Chen S and Liu H: Choice of
endogenous control for gene expression in nonsmall cell lung
cancer. Eur Respir J. 26:1002–1008. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Dekowski S and Snyder J: Insulin
regulation of messenger ribonucleic acid for the
surfactant-associated proteins in human fetal lung in vitro.
Endocrinology. 131:669–676. 1992.PubMed/NCBI
|
|
40.
|
Seidner S, Smith M and Mendelson C:
Developmental and hormonal regulation of SP-A gene expression in
baboon fetal lung. Am J Physiol. 271:L609–L616. 1996.PubMed/NCBI
|
|
41.
|
Liley H, White R, Warr R, Benson B,
Hawgood S and Ballard P: Regulation of messenger RNAs for the
hydrophobic surfactant proteins in human lung. J Clin Invest.
83:1191–1197. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Boggaram V and Margana R: Developmental
and hormonal regulation of surfactant protein C (SP-C) gene
expression in fetal lung. Role of transcription and mRNA stability.
J Biol Chem. 269:27767–27772. 1994.PubMed/NCBI
|
|
43.
|
Margana R and Boggaram V: Transcription
and mRNA stability regulate developmental and hormonal expression
of rabbit surfactant protein B gene. Am J Physiol. 268:L481–L490.
1995.PubMed/NCBI
|
|
44.
|
Huang H, Bi W, Jenkins G and Alcorn J:
Glucocorticoid regulation of human pulmonary surfactant protein-B
mRNA stability involves the 3’-untranslated region. Am J Respir
Cell Mol Biol. 38:473–482. 2008.PubMed/NCBI
|
|
45.
|
Planer B, Ning Y, Kumar S and Ballard P:
Transcriptional regulation of surfactant proteins SP-A and SP-B by
phorbol ester. Biochim Biophys Acta. 1353:171–179. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Venkatesh V, Iannuzzi D, Ertsey R and
Ballard P: Differential glucocorticoid regulation of the pulmonary
hydrophobic surfactant proteins SP-B and SP-C. Am J Respir Cell Mol
Biol. 8:222–228. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Mariencheck W and Crouch E: Modulation of
surfactant protein D expression by glucocorticoids in fetal rat
lung. Am J Respir Cell Mol Biol. 10:419–429. 1994. View Article : Google Scholar : PubMed/NCBI
|
